Violation Tracker Individual Record

Company: 
Mallinckrodt LLC
Current Parent Company: 
Mallinckrodt
Penalty: 
$35,000,000
Year: 
2017
Date: 
July 11, 2017
Primary Offense: 
Controlled Substances Act violation
Violation Description: 

Mallinckrodt LLC, a pharmaceutical manufacturer and one of the largest manufacturers of generic oxycodone, agreed to pay $35 million to settle allegations that it violated certain provisions of the Controlled Substances Act that are subject to civil penalties.

Level of Government: 
federal
Action Type: 
agency action
Agency: 
Drug Enforcement Administration
Civil or Criminal Case: 
civil
HQ Country of Parent: 
Ireland
Ownership Structure of Parent: 
publicly traded
Major Industry of Parent: 
pharmaceuticals
Specific Industry of Parent: 
pharmaceuticals
Source Notes: 
If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Parent company note: 
Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.